View in EDS

High agreement of Seegene Anyplex™ HPV 28 and Allplex™ HPV 28 for high-risk vaccine-type HPV detection in the KEN SHE Study.

Saved in:
Bibliographic Details
Title: High agreement of Seegene Anyplex™ HPV 28 and Allplex™ HPV 28 for high-risk vaccine-type HPV detection in the KEN SHE Study.
Authors: Heller KB; Massachusetts General Hospital, Infectious Diseases Division, Boston, MA, United States of America. Electronic address: kheller@mgh.harvard.edu., Mohamed JS; University of Nairobi/University of Washington, East Africa STI Laboratory, Mombasa, Kenya., Cherne SL; University of Washington, Department of Laboratory Medicine and Pathology, Seattle, WA, United States of America., Onono M; Kenya Medical Research Institute, Center for Microbiology Research, Kisumu, Kenya., Bukusi EA; Kenya Medical Research Institute, Center for Microbiology Research, Kisumu, Kenya; University of Washington, Department of Obstetrics and Gynecology, Seattle, WA, United States of America; Universityof Washington, Department of Global Health, Seattle, WA, United States of America., Njoroge BW; Kenya Medical Research Institute, Center for Clinical Research, Nairobi, Kenya., Kimanthi S; Kenya Medical Research Institute, Center for Clinical Research, Nairobi, Kenya., Hassan RM; University of Nairobi/University of Washington, East Africa STI Laboratory, Mombasa, Kenya., Rechkina EA; Universityof Washington, Department of Global Health, Seattle, WA, United States of America., McClelland RS; University of Nairobi/University of Washington, East Africa STI Laboratory, Mombasa, Kenya; Universityof Washington, Department of Global Health, Seattle, WA, United States of America; University of Washington, Department of Epidemiology, Seattle, WA, United States of America; University of Washington, Department of Medicine, Division of Allergy and Infectious Diseases, Seattle, WA, United States of America., Brown ER; University of Washington, Department of Biostatistics, Seattle, WA, United States of America; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, United States of America; Fred Hutchinson Cancer Center, Public Health Sciences, Seattle, WA, United States of America., Mugo NR; Universityof Washington, Department of Global Health, Seattle, WA, United States of America; Kenya Medical Research Institute, Center for Clinical Research, Nairobi, Kenya., Barnabas RV; Massachusetts General Hospital, Infectious Diseases Division, Boston, MA, United States of America; Harvard Medical School, Department of Medicine, Boston, MA, United States of America; Harvard School of Public Health, Department of Epidemiology, Boston, MA, United States of America.
Corporate Authors: KEN SHE Study Team
Source: Journal of virological methods [J Virol Methods] 2026 Jul; Vol. 344, pp. 115395. Date of Electronic Publication: 2026 Apr 08.
Publication Type: Journal Article; Randomized Controlled Trial; Comparative Study
Journal Info: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 8005839 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0984 (Electronic) Linking ISSN: 01660934 NLM ISO Abbreviation: J Virol Methods Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41962590
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: High agreement of Seegene Anyplex™ HPV 28 and Allplex™ HPV 28 for high-risk vaccine-type HPV detection in the KEN SHE Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Heller+KB%22">Heller KB</searchLink>; Massachusetts General Hospital, Infectious Diseases Division, Boston, MA, United States of America. Electronic address: kheller@mgh.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Mohamed+JS%22">Mohamed JS</searchLink>; University of Nairobi/University of Washington, East Africa STI Laboratory, Mombasa, Kenya.<br /><searchLink fieldCode="AU" term="%22Cherne+SL%22">Cherne SL</searchLink>; University of Washington, Department of Laboratory Medicine and Pathology, Seattle, WA, United States of America.<br /><searchLink fieldCode="AU" term="%22Onono+M%22">Onono M</searchLink>; Kenya Medical Research Institute, Center for Microbiology Research, Kisumu, Kenya.<br /><searchLink fieldCode="AU" term="%22Bukusi+EA%22">Bukusi EA</searchLink>; Kenya Medical Research Institute, Center for Microbiology Research, Kisumu, Kenya; University of Washington, Department of Obstetrics and Gynecology, Seattle, WA, United States of America; Universityof Washington, Department of Global Health, Seattle, WA, United States of America.<br /><searchLink fieldCode="AU" term="%22Njoroge+BW%22">Njoroge BW</searchLink>; Kenya Medical Research Institute, Center for Clinical Research, Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Kimanthi+S%22">Kimanthi S</searchLink>; Kenya Medical Research Institute, Center for Clinical Research, Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Hassan+RM%22">Hassan RM</searchLink>; University of Nairobi/University of Washington, East Africa STI Laboratory, Mombasa, Kenya.<br /><searchLink fieldCode="AU" term="%22Rechkina+EA%22">Rechkina EA</searchLink>; Universityof Washington, Department of Global Health, Seattle, WA, United States of America.<br /><searchLink fieldCode="AU" term="%22McClelland+RS%22">McClelland RS</searchLink>; University of Nairobi/University of Washington, East Africa STI Laboratory, Mombasa, Kenya; Universityof Washington, Department of Global Health, Seattle, WA, United States of America; University of Washington, Department of Epidemiology, Seattle, WA, United States of America; University of Washington, Department of Medicine, Division of Allergy and Infectious Diseases, Seattle, WA, United States of America.<br /><searchLink fieldCode="AU" term="%22Brown+ER%22">Brown ER</searchLink>; University of Washington, Department of Biostatistics, Seattle, WA, United States of America; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, United States of America; Fred Hutchinson Cancer Center, Public Health Sciences, Seattle, WA, United States of America.<br /><searchLink fieldCode="AU" term="%22Mugo+NR%22">Mugo NR</searchLink>; Universityof Washington, Department of Global Health, Seattle, WA, United States of America; Kenya Medical Research Institute, Center for Clinical Research, Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Barnabas+RV%22">Barnabas RV</searchLink>; Massachusetts General Hospital, Infectious Diseases Division, Boston, MA, United States of America; Harvard Medical School, Department of Medicine, Boston, MA, United States of America; Harvard School of Public Health, Department of Epidemiology, Boston, MA, United States of America.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22KEN+SHE+Study+Team%22">KEN SHE Study Team</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228005839%22">Journal of virological methods</searchLink> [J Virol Methods] 2026 Jul; Vol. 344, pp. 115395. <i>Date of Electronic Publication: </i>2026 Apr 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2FNorth-Holland+Biomedical+Press%22">Elsevier/North-Holland Biomedical Press </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8005839 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0984 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201660934%22">01660934 </searchLink><i>NLM ISO Abbreviation: </i>J Virol Methods <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41962590
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jviromet.2026.115395
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 115395
    Titles:
      – TitleFull: High agreement of Seegene Anyplex™ HPV 28 and Allplex™ HPV 28 for high-risk vaccine-type HPV detection in the KEN SHE Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Heller KB
      – PersonEntity:
          Name:
            NameFull: Mohamed JS
      – PersonEntity:
          Name:
            NameFull: Cherne SL
      – PersonEntity:
          Name:
            NameFull: Onono M
      – PersonEntity:
          Name:
            NameFull: Bukusi EA
      – PersonEntity:
          Name:
            NameFull: Njoroge BW
      – PersonEntity:
          Name:
            NameFull: Kimanthi S
      – PersonEntity:
          Name:
            NameFull: Hassan RM
      – PersonEntity:
          Name:
            NameFull: Rechkina EA
      – PersonEntity:
          Name:
            NameFull: McClelland RS
      – PersonEntity:
          Name:
            NameFull: Brown ER
      – PersonEntity:
          Name:
            NameFull: Mugo NR
      – PersonEntity:
          Name:
            NameFull: Barnabas RV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0984
          Numbering:
            – Type: volume
              Value: 344
          Titles:
            – TitleFull: Journal of virological methods
              Type: main
ResultId 1